Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03099486
Title Regorafenib Plus 5-Fluorouracil/Leucovorin Beyond Progression in mCRC
Recruitment Suspended
Gender both
Phase Phase II
Variant Requirements No
Sponsors Fox Chase Cancer Center
Indications

colorectal cancer

Therapies

Fluorouracil + Leucovorin + Regorafenib

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.